# 18HHS LLC – FDA Inspection, Jun 1, 2026

Source: https://www.keypedia.com/records/fda_inspections/18hhs-llc/1dd60029-e0c1-4dce-a07e-657ca07e4e21
Source feed: FDA_Inspections

> FDA inspection 1319908 of 18HHS LLC, June 01, 2026. 3 citations under 21 CFR part 1271. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1319908
- Company Name: 18HHS LLC
- Inspection Date: 2026-06-01
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 3

## Related Officers

- Issuing Officer
- [Issuing Officer](https://www.keypedia.com/people/elyshia-q-danaher/73046c15-abb1-431e-8a76-59c7e8c1604a)

Company: https://www.keypedia.com/companies/18hhs-llc/080e3f97-ff79-491a-a824-e33814e7d25d

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9